Membrane lipids regulate glycosphingolipid catabolism, its ... · LIMES, Membrane Biology and Lipid Biochemistry Unit Kekulé-Institut Gerhard-Domagk-Str. 1, 53121, Bonn Universität

Sphingomyelin

O CH3

HN CH3

O

OHP

ON

OOCH3

H3C

H3C

Konrad SandhoffLIMES, Membrane Biology and Lipid Biochemistry UnitKekulé-InstitutGerhard-Domagk-Str. 1, 53121, BonnUniversität Bonn

Membrane lipids regulate glycosphingolipid catabolism, its

enzymes and lipid binding proteinsPhiladelphia, Aug. 2015

Inside

Outside

3 Na+

2 K+

ATPase

Electro-

chemical

potential,

Gradients

CeramideGanglioside GM1OH

HOOH

O

OH

O

OH

OHHO

O

O

AcHN

O

OH

OOH

O

O

OHOH

O

OH

O

HOOC

HO

OH

HO

CH3

HN CH3

O

OH

AcHN

-Gangliosides, SM & Chol. stabilize

neuronal membranes.

-However, Chol. & SM inhibit lysos.

catabolism of ganglioside GM2.-

Plasma membrane

SAPCD1-

loading

HydrolysisGlycocalix

CD1b

NPC-1

ASMNPC-2

Late endosome

Early endosome

Golgi

ER

LysosomeTemporal fusionand discharge

Sorting

Sorting

Vesiculartransport? LLBPs

Principles of lysosomal sphingolipid catabolism

and membrane digestion

pH Chol BMP

7.4

6.0

5.0

4.5

Gallala et al., J. Neurochem. 2011

Luminal vesicles (LV) are

platforms for SL, GSL-

and membrane-

degradation

1. Late endosomes:

Maturration of IMs by

removal of Chol (NPC1,

NPC2, NPC disease)

2. Lysosomes:

Degradation by enzymes

and LLBPs (GM2AP, Sap

A,B,C,D) :

Inherited defects cause

fatal diseases, lipid and

membrane storage,

loss of permeability

barrier in the skin,

and affect CD1 loading

3. KO mice are available

LV

LV

At late endosomes: Membrane lipids & ASM regulate

cholesterol transfer by NPC-2

Abdul-Hammed et al., J. Lipid Res. 2010

DONOR ACCEPTOR

+ endolysosomal

lipid

binding protein

Separation of

donor (pellet) and

acceptor (supernatant)

Analysis of

acceptor in

supernatant

Fluorescence

Radiolabeled [14C] lipid NBD-PE Biotin-PE host lipids

DONOR ACCEPTOR

+ endolysosomal

lipid

binding protein

Separation of

donor (pellet) and

acceptor (supernatant)

Analysis of

acceptor in

supernatant

Fluorescence

Radiolabeled [14C] lipid NBD-PE Biotin-PE host lipids

0

20

40

60

0 10 20

lipid concentration [mol%]

Ch

ole

ste

rol tr

an

sfe

rre

d

(% o

f to

tal ra

dio

activity in

su

pe

rna

tan

t/ 1

0 m

in/

0.0

92

nm

ol N

PC

2/ 2

00

µl) Cer +

BMP

SM

B

20 mol% BMP

Cer

0

10

20

30

40

50

0 30 60 90 120

Pre-incubation time of vesicles with ASM

[min]

Ch

ole

ste

rol tr

an

sfe

r

[% o

f to

tal ra

dio

activity in

sup

ern

ata

nt/ 0

.5 m

M N

PC

2/

10

min

]

8.0

8.5

9.0

9.5

10.0

SM

co

nce

ntra

tion

[mo

l%]

0

10

20

30

40

50

0 30 60 90 120

Pre-incubation time of vesicles with ASM

[min]

Ch

ole

ste

rol tr

an

sfe

r

[% o

f to

tal ra

dio

activity in

sup

ern

ata

nt/ 0

.5 m

M N

PC

2/

10

min

]

8.0

8.5

9.0

9.5

10.0

SM

co

nce

ntra

tion

[mo

l%]

0

10

20

30

40

4.2 5.0 6.0 7.4pH

Lip

id t

ran

sfe

rre

d

(% o

f to

tal ra

dio

activity in

su

pe

rna

tan

t/ 1

0 m

in/

0.0

92

nm

ol N

PC

2/ 2

00

µl)

Chol Sulf

PE PCGM3 GalCer

Cer

A

0

10

20

30

40

4.2 5.0 6.0 7.4pH

Lip

id t

ran

sfe

rre

d

(% o

f to

tal ra

dio

activity in

su

pe

rna

tan

t/ 1

0 m

in/

0.0

92

nm

ol N

PC

2/ 2

00

µl)

Chol Sulf

PE PCGM3 GalCer

Cer

AC

Oninla,Breiden, Sandhoff, 2014

Chol.-storage in NPC disease triggers GM2 & GSL accumulation

ASM is regulated by membrane lipids

0

5

10

15

20

0 100 200 300 400 500 600

ASM [ng]

PA

hyd

roly

sed

[%/2

h /3

7°

C]

PA

PG

BMP

w/o

PA

C

0,0

0,2

0,4

0,6

0,8

1,0

0 100 200 300 400 500 600

ASM [ng]

PE

hyd

roly

sed

[pm

ol/ 2

h/ 3

7°

C]

PAPE

D

Liposomes: 10 mol% Cholesterol; 10 mol% SM ; 0 or 20 mol% anionic lipids ; 80 or 60 mol% DOPC

ASM: recombinat human ASM expressed in insect Sf21 cells (Lansmann et al., 2000)

0

50

100

150

200

250

0 100 200 300 400 500 600

hyd

roly

ze

d l

ipid

[p

mo

l/ h

/ p

H 5

.0/ 3

7°C

]

ASM [ng/50 µl]

SM

PA

PG

BMP

w/o

A

0

50

100

150

200

250

0 100 200 300 400 500 600

hyd

roly

ze

d l

ipid

[p

mol/ h

/ pH

5.0

/ 37

°C]

ASM [ng/50 µl]

PC

PA

PG

BMP

w/o

B

Oninla, Breiden et al. (2014) JLR

Electrostatic binding of ASM to liposomes

Oninla et al., JLR 2014

�

0 50 100 150 200 250 300 350

0

1000

2000

3000

4000

5000

6000

7000

Time [s]

Resp

on

ce U

nit

s [

RU

]

EPC

neutral

MVL5

DOTMA

control (w/o liposomes)

baseline: w/o ASM

PG

PA

BMP

DHPPIPS

Association phase (ASM) Dissociation phase (buffer)

10 mol% Cholesterol

10 mol% SM

20 mol% anionic or cationic lipid

60 mol% DOPC

Zeta potential [mV ]

of liposomes

PG - 24.65

PA - 24.48

BMP - 26.53

PS - 23.58

PI - 21.50

DHP - 22.45

Neutral

(PC)

DOTMA

0.11

22.21

EPC 23.44

Infantile Amaurotic Idiocy:

cherry red spot

Tay-Sachs Disease:

Neuronal MCBs, Lysosomal storage

TSD is a recessive and lethal ganglioside storage disease

Wright et al. (2003) J Mol Biol. 331, 951-64

Wendeler et al. (2004) Eur. J. Biochem. 271:614-27

C(n=5,1)-TPD-GM2

(CH2)n

O F3C

NNO

OH

HNHO

HOHO

O

O OH

O OH

O

OHHOO

OH

O

HN

OH

HOOC

O

OH

HONH

O

OH

O

h*

Mechanism of GM2AP-Liftase

IM, luminal

vesicle

Michaelis-

Menten

Complex

Surface,

Plasmon

Resonance,

Biacore

BMP (PA&PI) stimulate

hydrolysis of liposomal GM2

by Hex A and GM2AP

BMP mobilizes membrane

lipids by GM2AP

BMP stimulates inter-

vesicular lipid transfer

by GM2AP

Anheuser et al.(2015),

JLR

Cholesterol

inhibits hydrolysis of

liposomal GM2 by

Hex A & GM2AP

Cholesterol

Inhibits solubilization

of M-lipids by GM2AP

Cholesterol inhibits

Intervesicular transfer

M-lipids by GM2AP

Biacore

Anhheuser et al.,

(2015) JLR

NPC: Lysosomal

cholesterol

accumulation

inhibits lysosomal

GM2 catabolism,e.g.

In NPC disease

Q: Is solubilization of

M-lipids by SAPs

physiologically

relevant?

H N

O H

O

O

O

O H

O H

O

S

O

O

O

H

R

RLyso = H2

O

RC18

=

O

RC2

=

O

RC6

=

0

100

200

300

400

500

600

Lyso C2 C6 C18

Acyl chain length (R)

+ Sap-B

- Sap-B

Deg

rad

atio

n r

ate

(pm

ol/

h x

mU

en

zym

e)

Vogel et al. (1991) EJB 200, 591-597

Lysosomes:

Lipid phase problem, sulfatide cleavage

( Also LUV-bound GlcCers by beta-Glcase, GM2 by Hex A, GM1 by beta-Galase )

Glycosylation of Sap- B is essential for its

physiological functions

Sap-B

Glycosylated Unglycosylated

Causing MLD(glycosylation site variants)

▬1,2 + 1,2

Rescue of Sap-B deficient cells + 3,4 ▬

4

Stimulation of sulfatide

degradation

(micellar/ liposomal assays)+ 4 ++ 4

Lipid transfer (sulfatide etc.) + 5 (+) 6

SPR (liposomes adsorbed on chip):

Lipid binding

Lipid mobilization

+ 4

++ 4

+ 4

▬4

In vitro:

Lipid modifiers may contribute to clinical heterogeneity of

lysosomal diseases

- BMP & other anionic PLs enhance

a) cholesterol transfer by NPC2

b) the hydrolysis of SM by ASM, of GM1 by ß-Galase, and of GM2 by Hex A

c) the mobilization of membrane lipids by SAPs

d) transfer of 2-NBD-GM1 by GM2AP

e) the activities of GM2AP, Sap A & B etc.

- Cholesterol levels inhibit:

Hydrolysis of GM2 by Hex A (in NPC2), PC by ASM, mobilization of lipids by

Sap A,B & GM2AP, transfer of 2-NBD-GM1 by GM2AP

- SM inhibits cholesterol transfer by NPC2 (in NPA&B), hydrolysis of GM2 by

Hex A , and mobilization of membrane lipids by GM2AP

- Turnover of GM2 by Hex A, mobilization of membrane lipids and transfer of 2-

NBD-GM1 by GM2AP are dependent on a narrow pH range of 4.2 +/- 0.4

(Hex A range: pH 3 – 7)

- The His6-tag changes capabilities of GM2AP :

It stimulates of hydrolysis of liposomal GM2 by Hex A, but inhibits lipid

mobilization completely. It triggers vesicle fusion.

Misbaudeen Abdul-Hammed

Bernadette Breiden

Susi Anheuser

Günter Schwarzmann

Coworkers

vi

vmax

Lysosome

Substrate influx: vi

Degradation rate: vmax

[S]eq/Km = 1/[(vmax/vi)-1]

A

B

Critical threshold activity .....

Ste

ady

sta

tesubstr

ate

con

ce

ntr

atio

n[S

] eq

/K

m

Hypothetical solubilityof substrate

0.5

1.0

1 5 10 2015

5

15

10

Turn

ove

rra

teo

fsu

bstr

ate

v/v

i

Enzyme activity Vmax/vi

0

0

10

20

30

40

50

200 400 600 800 1000 1200

Tu

rno

ve

r ,%

of

incor p

or a

ted

GM

2

Hexosaminidase activity, pmol cleaved GM2 / h x mg x AU

Normal

Heterozygotes

Adult

Juvenile

Infantile

GM2-Activator deficiency

Threshold Theory

1. Wrobe D, Henseler M et al. (2000) A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD)." J Inherit Metab Dis 23(1): 63-76

2. Regis S., M. Filocamo, et al. (1999). "An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity." Eur J Hum Genet 7(2): 125-30

3. Matzner , U., B. Breiden, et al. (2009). "Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy." J Biol Chem 284(14): 9372-81

4. Remmel , N., S. Locatelli-Hoops, et al. (2007). "Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity." Febs J 274(13): 3405-20

5. Vogel A., G. Schwarzmann, et al. (1991). "Glycosphingolipid specificity of the human sulfatide activator protein." Eur J Biochem200(2): 591-7

6. Abdul-Hammed, M., B. Breiden, et al. "Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion." J Lipid Res 51(7): 1747-60

(GM1-Gangliosidosis)

GM1 galactosidase-b-

Sialidase

Arylsulfatase A

b-

b-HexosaminidaseA

HexosaminidaseB

b-Galactosyl-ceramidase

Sphingomyelinase

(Niemann-PickType A, B)

GalCer galactosidase

GM1 galactosidase

-b-

-b-

Ceramidase

(GM2-Gangliosidoses,AB, B, 0 Variant)

(Sialidosis)

a-Galacto-sidase A

(Fabry)

(Sandhoff)

(Fabry)

(Krabbe)

(Metachromaticleukodystrophy)

(Gaucher)

(Farber)

GM1

GM2

GM3

LacCer

GlcCer

Cer

Sphingosine

Sulfatide

DiGalCer

Globotriaosylceramide

Globoside

GalCer

Glucosylceramidase

a- GalactosidaseA

b-Hexosaminidase


GM1 galactosidase-b-GM1 galactosidase-b-

Sialidase

Arylsulfatase A

b-

b-HexosaminidaseA

HexosaminidaseB


Sphingomyelinase



GM1 galactosidase

-b-

-b-

Ceramidase

(GM2-Gangliosidoses,

(Sialidosis)

a-Galacto-sidase A

(Fabry)

(Sandhoff)

(Fabry)

(Krabbe)


(Gaucher)

(Farber)

GM1

GM2

GM3

LacCer

GlcCer

SphingomyelinCer

Sphingosine

Sulfatide

DiGalCer


Globoside

GalCer

Glucosylceramidase

a- GalactosidaseA

b-Hexosaminidase

Sap-C, Sap-D

GM2AP, Sap-

B

Sap-B

Sap-B, Sap-C

Sap-C,

Sap-B

Sap-B

Sap-B

Sap-C

GM2-AP

Lysosomal & extracellular GlcCer degradation: Protein & lipid modifiers

Sandhoff, K. and Kolter, T. (1995) Naturw., 82, 403-413

Amaurotic idiocy: 5 genetic

diseases:

GM1- and 4 forms GM2-

gangliosidoses (Var AB, B, B1, 0)

Hex A deficiency: various clinical

courses (inf. juv. adult chron.),

Threshold theory

Coworker:

Bernadette Breiden


Günter Schwarzmann

Susi Anheuser

Konrad Sandhoff, LIMES,

University of Bonn

Skin biopsy of a pSap-

deficient patient

(W. Roggendorf)

Feeding of pSAP reverses membrane storage

Burkhardt et al. (1997)

Bis(monoacylglycero)phosphate (BMP, S-configuration, sn1)

Wilkening, Linke, Sandhoff (1998) J. Biol. Chem. 273, 30271-8

• Electrostatic interaction: Cationic

proteins bind to anionic vesicles

• SAPs stimulate enzymatic

hydrolysis of liposome-bound

sphingolipids.

• BMP and other anionic PLs

stimulate degradation of:

- Cer, GlcCer, SM, GM1, GM2:

3-15 fold in the presence of SAPs.

(Sensitivity to CADs)

Lysosome

-

-

-

-

-

-

-

-

-

-

-

--

HO

Sap-CSap-D

acid

Ceramidase

Gluco-

cerebrosidase

CeramideGlucosylceramide

BMPBMP

Intralysosomal vesicles

GlycocalixLysosomal membrane

active siteactive site

Activator protein

Lysosomal enzyme

P

O

O

O

OOHH

OC

O

ROHH

ORC

O

P

O

O

O

O

OHHO

C

O

ROHH

ORC

O

P

O

O

O

O

OHHO

C

O

ROHH

ORC

O

-

+

-

+

+

+++

++

+

+

+

+

+

+

-

-

-

-

+

Sphingolipid degradation at intralysosomal membrane surfaces:

Stimulation by SAPs and anionic lipids

Sandhoff ,Proc. Jpn. Acad. Ser. B, Vol. 88,

554-82 (2012)

Lysosomal anionic lipids enhance the degradation of GM1 by β-galactosidase, but only in the presence of SAPs

Wilkening G et al. (2000) J. Biol. Chem. 275, 35814-35819

Lysosomal anionic lipids (10 mol %) were incorporated in LUVs, composed of 10 mol % GM1, 20 mol % cholesterol, and 60 mol % PC. Assays in the absence of an activator protein and in the presence of 5 μm GM2-AP or 5 μm SAP-B were carried out.

Lysosomal lipids in LUVs stimulate the enzymatic GlcCer hydrolysis in the presence and also in the absence of Sap-C.

A: Assays were conducted with GlcCer as substrate in the absence (○) and presence of

Sap-C (2.5 μm) (•), using LUVs with various proportions of synthetic BMP (0–40 mol %).

B: Assays were carried out with varying concentrations of PI in LUVs, with (•) and without (○) the addition of 2.5 μm Sap-C, keeping the total lipid concentration in the assays constant.

Wilkening G et al. J. Biol. Chem. 1998;273:30271-30278

+ Sap-C

- Sap-C

-- Several inherited diseases can generate the same clinical

phenotype ( amaurotic idiocy caused by GM1&GM2 gangliosidoses ( TSD, SD, Var AB & B1 )

-- Mutations in the same gene (e.g.Hex A ) can cause different

clinical courses (inf., juv., adult & chronic courses due to different levels of residual

catabolic activities )

-- Catabolic activity of an enzyme ( e.g. Hex A ) is strongly modified

by the microenvironment in which the enzymic reaction occurs,

e.g. at the surface of liposomes ( or in vivo at the surface of

luminal lysosomal vesicles ) ( pH-value, ionic strength, LTPs or SAPs,

lipid composition of the GM2 carrying membrane: anionic M-lipids stimulate ( up to 15 fold ),

cholesterol inhibits strongly

Conclusions----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

-- No direct correllation between gene mutations and the clinical

course of a disease, the microenvironment of the enzymic

reaction modifies the catabolic rate.

Ceramide metabolism: Key to skin barrier function

Epidermis is important

against desiccation and infections

Barrier : Extracellular lipid layers :ULC-Cers

,ULC-FA, Cholesterol

N

H

O

O

OO

OOH

NNNNNNNN

R HH

R

RHRH

R

R O

O

O

O

O

O

O

H H H H

OO

HN

O

OHOH

OO

HN

O

OOH

OHO

O O

OH

HH

O

OO HN

O

O

OHOHHO

HO

OH

Permeability barrier of the skin

Golgi

Stra

tum

co

rne

um

Skin surface

AcylCer

Lipid

matrix

?

?Trans-

esterification

AcylGlcCer

Lip

id-b

ou

nd

en

ve

lop

e

Corneocyte

AcylGlcCer

CETrans-

esterification

b-GlcCerase

Sap-C

Glc

Glc

Acid Ceramidase

Sap-D, -C b-GlcCerase

Sap-C

w-O

H-C

er

w-O

H-G

lcC

er

w-O

H-f

att

y a

cid

PM

AcylGlcCer (EOS)

Stra

tum

gra

nu

los

um

CE

Lamellar body

Breiden & Sandhoff, 2013

R12-LOXeLOX3

HOO

Cong. icht.

Collod. babies

Collod. babies

template

Ultrastructure of pSAPknockout epidermis

Ruthenium staining reveals that thepSAP-deficient interstices (B, betweenarrows) lack the regular, compactpattern of lamellar membranesobserved in normal, pSAP-replete SC(C, between open arrows)..

Doering, T. et al. J Biol Chem, 274, 11038-11045

Biosynthesis of AcylGlcCer

AcylGlcCer

Glc

Golgi

ER

L-Serine

Palmitoyl-CoA

OO

O

NHO

O

HO

HO

OO

OH

HH

OO

NHO

OH

HO

AcylGlcCer

AcylCer

OH

NHO

OH

HO

Sphinganine

Cytosol

w-OH C16 FA-CoA

w-OH FA (C28)-CoA

Lipid droplet

DAG TAG Linoleic acid

PM

CerS 3

w-Hydroxylation

FA-elongation

complex

(ELOVL 1,3,6,7)

ELOVL 4

DAGT2Lipase

CGI 58

GlcCer-

synthase

(Ugcg)

Lamellar

body

w-OH-CerSPT

ABCA12

Breiden & Sandhoff, 2013

w-OH FA (>C28)-CoA

Alternative pathway

1. UDP-Glucose

2. Linoleoyl CoA

w-OH FA (<C24)-CoAELOVL 1, 4 Harlequin icht.

Dorfman-Chanarin S.

Cong. ichthyosis

Schemes of CerS3d/d phenotypic alterations with proposed cascades of events.

Jennemann R et al…..Sandhoff R, (2012) Hum. Mol. Genet.; 21:586-608

© The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]

• CerS3 ko mice die shortly after birthfrom TEWL

• Loss of all SLs with acyl residues longer than 24 C-atoms, lack of protein-bound ceramides

• Lack of continuous extracellularlipid lamellae, water loss, hyperkeratosis

• High skin susceptibility to Candida infection

• SG –SC interface: absense of LBexocytotic figures and lamellar lipid-free domains

• Impaired processing of epidermalproteins: (pro) filaggrin, involucrin, loricrin.

High skin susceptibility to Candida infection

Jennemann R et al. .Sandhoff R (2012) Hum. Mol. Genet. 21:586-608

© The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]

(A–C′) Cultured skin samples of CerS3d/d mice reveal after inoculation with C. albicans increased microbial adhesion and growth after 6 h (A′), microbial invasion of all epidermal layers after 24 h (B′) and microbial colony formation within SS in parallel to migration of pseudohyphae into the dermis after 66 h (C′, the residual basement membrane, red arrowheads). Note the abundance of immune cells in mutant dermis after 66 h. PAS-hemalaun.

Principles of molecular and cellular pathology

- Cell type specificity of GSL- & SL- biosynthesis

- Promiscuity (and redundancy) of hydrolases and SAPs

- SAPs are multifunctional proteins (lipid binding & mobilization, intermembrane lipid transfer and vesicle fusion)

- Membrane lipids are strong regulators of lipid degradation at vesicular surfaces

-Unknown transient levels of cholesterol & anionic lipids in luminal vesicles oflysosomes may contribute to clinical heterogeneiety of diseases

- ULC-Glc-Ceramides & ULC-Ceramides are key components of the water & immunebarrier of mammalian skin. Defects in their metabolism can cause ichtiosys and areoften fatal

Liposomal activity assay

- Uncharged liposomes contained: 5 mol% cholesterol, [14C]-GM2 and PC as a host lipid

- negatively charged liposomes contained additional 20 mol% BMP, PI or PG, positively charged liposomes

contained 20 mol% MVL5 or EPC

Adding negative charged lipids in the liposomal membranes resulted in a strong enhanced hydrolysis of of

GM2 by HexA in presence of GM2AP. Using positively charged liposomes, the hydrolysis rate of GM2 was as

low as that observed with unchaged vesicles.

0

0,1

0,2

0,3

0,4

0,5

PI PI +30 mmol/l

desipramine

PG PG +30 mmol/l

desipramine

GM2AP-His6

GM2AP

Tu

rno

ver

of

GM

2[p

mol/h/p

mol G

M2A

P]

Hydrolysis of liposomal GM2 by HexA

Liposomal activity assay

- The negatively charged liposomes contained 20 mol% PI or PG, 5 mol% cholesterol, [14C]-GM2 and PC as

a host lipid. Adding desipramine to the assay preparation (30 mmol/l final concentration), the hydrolysis of

GM2 by HexA in presence of GM2AP was strongly reduced.

- The cationic anphiphilic drug desipramine is desturbing the interaction of GM2AP with the vesicle

membrane, most likely by its positive netcharge.

0

500

1000

1500

2000

2500

3000

3500

0 200 400 600 800 1000time [s]

baseline

GM2AP desipramine30 mmol/l

buffer

RU

Desipramine strongly reduces membrane binding of GM2AP

Negatively charged liposomes containing 5 mol% cholesterol, 5 mol% BMP and 10 mol% GM2 were immobilized on

a Pioneer HPA-chip. Running buffer was 20 mM sodium citrate buffer (pH 4.2). Response signals measured after binding of

membrane lipids were defined as zero (baseline: orange). GM2AP (0.2 mM) in running buffer was injected into the flow cells

at a rate of 20 µl/min. Afterwards, desipramine (30 mmol/l, dissolved in water) was injected for 3 min (flow rate 20 µl/min),

followed by buffer alone.

The cationic anphiphilic drug desipramine is desturbing the interaction of GM2AP with the vesicle membrane, most likely by

its positive netcharge.

Surface plasmon resonance (SPR) study

Cell type specific biosynthesis of glycosphingolipids

van Echten et al. (1989)

J. Neurochem. 52, 207-214

GM1

OH

OHO

NH

HOOH

OH

O

O

HO

O

OH

O OH

HOO

HO

O

COOHO

OH

O

NH

O

OH

OHO

OH

OH

NH

O

HO

O

Combinatorial Ganglioside Biosynthesis

GM1b

GA1

GA2

LacCer

GlcCer

GD1a

GM1a

GM2

GM3

GT1b

GD1b

GD2

GD3 GT3

GT2

GT1c

GQ1c

GP1c GP1c aGQ1b GQ1b aGT1a Gt1GD1c GD1a

GalT I

SAT I SAT II SAT IIIGalNAcT

GalT II

SAT IV

SAT V, SAT x

NeuAc a 2,8-

NeuAc

NeuAc a2,6-

GalNAc

0-series a-series b-series c-series

Cer

GlcTA

B

C D

E

aPM

ER

Golgi

TGN

Kolter, Proia, Sandhoff (2002) J. Biol. Chem. 277, 25859-62

lum

ina

l sid

e

O

O

OH

OH

O

OH OH

OH

O

O

-OOC

OHHO

HO

OHAcHN

O (CH2)12CH3

OH

NH

O

(CH2)16CH3

HO

GM3

A: lethal at embryonic day 6,

apoptosis in ectoderm (*)

D: normal life spanE: infertile (testis), myelin

D+E: "GM3 only", sudden

death, audiogenic

seizures

C: early death, formation of

0-series glycolipids,

infantile epilepsy

C+E: early death,

LacCer-3-sulfate

(*) neuron-, hepatocyte-,

keratinocyte-specific ko-

mice are born

Linke T et al. J. Biol. Chem. 2001;276:5760-5768

LUVs and SUVs with

varying mean diameter

either contained none or 25

mol % PI. In addition,

incubation mixtures

contained either none or 2.5

μm SAP-D.

Sap-D, PI and increased membrane curvature enhance

ceramide hydrolysis by aCerase

Wilkening, et al. (1998)

1. Induction of lipidoses in rats Lüllmann et al. (1978)

2. Detachment of acid sphingomyelinase from anionic

liposomes Kölzer et al. (2004)

3. Proteolytic degradation of acid sphingomyelinase and

other lysosomal enzymes by desipramine-treated

cultured fibroblasts. Hurwitz et al. (1994)

Cytoplasmic Inclusion body; x 78400

Chromaffin cell of a rat treated with

1-chloro-amitriptyline (120 mg/kg 10 wk)

N

NH

CH3

N

CH3

CH3

Cl

Chloroquine(Antimalaria)

N

NCH3

H

Desipramine(Antidepressant)

Propranolol(b-Adrenoreceptor-antagonist)

Many drugs are cationic amphiphilic lipids

(CADs) :

CADs are partially neutral at pH 7, penetrate mem-

branes, and are protonated & trapped in lysosomes.

Lysosome

-

-

-

-

-

-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP

intralysosomal Vesicles

Glycocalixlysosomal Membrane


activator protein

lysosomal enzyme

-

++

+

+++

++

+

+

+

+

+

+

-

-

-

-

+

LysosomeLysosome

-

-

-

-

-

-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP



-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP




activator protein

lysosomal enzyme

--

++++

++

++++++

++++

++

++

++

++

++

++

--

--

--

--

++

O N CH3

CH3

OH H

CADs: Cationic amphiphilic drugs (lipophilic)

induce a phospholipidosis: the molecular view

BMP and PI stimulate the degradation of membrane-bound ceramide in the absence of SAPs

BMP


Acid ceramidase activity was measured in the presence of increasing concentrations of BMP (▪) and PI (●) in ceramide-bearing LUVs in the absence of SAPs. The data presented are the means of three determinations. All individual values were in the range of ±5 up to ±10% of the mean.

Rate increases with curvature of liposomes

Sap-D stimulates up to 3fold

PI

Skin biopsy of a pSap-

deficient patient

(W. Roggendorf)

Feeding of pSAP reverses membrane storage

Burkhardt et al. (1997)

0.0

0.5

1.0

1.5

2.0

Ce

r [mo

l%]

1000

1500

2000

2500

3000

0 20 40 60 80 100

Pre-incubation time of vesicles with

ASM [min]

Ch

ole

ste

roltr

an

sfe

r

[nm

ol/h/m

gN

PC

2atpH

5.0

]

8.0

8.5

9.0

9.5

10.0

SM

[mo

l%]

with ASM control: w/o ASM

Degradation of SM by ASM stimulates

intervesicular cholesterol transfer by NPC2

Sandhoff, K. and Kolter, T. (1995) Naturwissenschaften, 82, 403-413

Lysosomal Sphingolipid Degradation

GM 1 galactosidase-b-

SialidaseSAP -B

Arylsulfatase ASAP -B

SAP -B

b-

b-Hexosaminidase A

Hexosaminidase B

b-Galactosyl -ceramidaseSAP -C

Sphingomyelinase


GM1 galactosidase

-b-

-b-

Ceramidase

Sialidosis

a-Galacto -sidase A

SAP -B

GM1

GM2

GM3

LacCer

GlcCer

Cer

Sphingosine

Sulfatide

DiGalCer


Globoside

GalCer

SAP -C, SAP -D

SAP -C

Glucosylceramidase

a- Galactosidase A

SAP -B, SAP -C

GM2 -AP, SAP -B

b-Hexosaminidase

GM2 -AP

GM 1 galactosidase-b-GM 1 galactosidase-b-

SialidaseSAP -B

Arylsulfatase ASAP -B

SAP -B

b-

b-Hexosaminidase A

Hexosaminidase B

b-Galactosyl -ceramidaseSAP -C

Sphingomyelinase


GM1 galactosidase

-b-

-b-

Ceramidase

a-Galacto -sidase A

SAP -B

GM1

GM2

GM3

LacCer

GlcCer

SphingomyelinCer

Sphingosine

Sulfatide

DiGalCer


Globoside

GalCer

SAP -C, SAP -D

SAP -C

Glucosylceramidase

a- Galactosidase A

SAP -B, SAP -C

GM2 -AP, SAP -B

b-Hexosaminidase A

GM2 -AP

GM1 Gangliosidosis

GM2 Gangliosidosis

AB, B, O Variant

Gaucher

Farber

Niemann-Pick

Type A, B

Krabbe

Metachromatic

leukodystrophy

Fabry

Fabry

Sandhoff

, SAP-A

Coworkers:

Bernadette Breiden

Vincent Oninla

Günter Schwarzmann

Susi Anheuser

Previous Coworkers:


Natascha Remmel

Silvia Locatelli-Hoops

Wiebke Möbius

Michaela Wendeler

Melanie Kölzer

Thomas Döring

rgl Sap-B (5 µM)

-2000

-1000

0

1000

2000

0 100 200 300 400

Time (s)

Resp

on

se U

nit

s (

RU

)

pH 4.2

pH 7.0

pH 5.5

Sap-B: variant forms

-2000

0

2000

4000

6000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

r Sap-B,

deglycosylated

r Sap-B, Asn215His

r Sap-B, Asn215Gln

rgl Sap-B

Patient:

rgl Sap-B / BMP 20 mol%

-5000

-3000

-1000

1000

3000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

0

40

20

Chol

(mol %)

5

3825

BMP 14 mol%

g-Sap-B mobilizes lipids from BMP rich and

cholesterol poor membranes at acidic pH values

Surf. Plasmon resonance, Remmel, N. et al. (2006)


-5000

-3000

-1000

1000

3000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

0

40

20

Chol

(mol %)

5

3825

Localization of Biotin-GM1 on

Cryosections:

Human fibroblasts were incubated with

10µM Biotin-GM1 for 72 h at 37°C.

B: double labeling with anti-caveolin-1

(arrowheads) and anti-biotin (large

gold)

D: double labeling with anti-acid

phosphatase (arrowheads) and anti-

biotin (large gold)

E: double labeling with anti-LIMP

(arrowheads) and anti-biotin (large

gold)

Möbius, Herzog, Sandhoff,

Schwarzmann (1999). J. Histochem.

Cytochem. 7

bar=200 nm

*

OHHO

OHO

O

OH

ONH

OOH

HOO

O

O

HN

OH

OO

O

OHO

OH

OH

HOOH

COO-

HOOH

HO

O

HO

H

H

O

NH

O

NHS

HN

NHO

*

OHHO

OHO

O

OH

ONH

OOH

HOO

O

O

HN

OH

OO

O

OHO

OH

OH

HOOH

COO-

HOOH

HO

O

HO

H

H

O

NH

O

NHS

HN

NHO

* Position of radiocarbon

• Cholesterol transfer by NPC2 between vesicles (and cholesterol egress from late

endosomes) is stimulated by BMP and other anionic lipids, and inhibited by SM

down to 10%.

• ASM is stimulated by anionic lipids (PG, PA, BMP) up to 14 fold, but not inhibited

by cholesterol.

• Results suggest a sequential pathway of lipid degradation at intraendosomal

vesicles during endocytosis:

- At late endosomes PM derived anionic PLs (PG, PA) stimulate ASM to degrade

SM, thereby releasing the block of NPC2 mediated cholesterol egress. ASM also

degrades PG, PA, and other PLs, triggering loss of bilayer structure and barrier

function of luminal membranes.

- Generation of BMP and reduction of cholesterol levels in intralysosomal vesicles

activates SAPs (and hydrolases) needed for effective degradation GLS and

ceramides.

- Cationic lipids are toxic and inhibit catabolic steps (GalSo (Krabbe), GlcSo

(Gaucher), So, Sa). CADs trigger proteolysis of ASM & other hydrolases and

induce a phospholipidoses.

Perspectives for endocytosis and sphingolipid digestion

LLBPs are small glycoproteins, generated from big precursors by proteolysis

in endolysosomes. Their activity is regulated at acidic pH by membrane lipids:

Some (NPC2, Saps A, B, C) bind and lift membrane lipids from surfaces of

liposomes.

Some form soluble stochiometric lipid protein complexes (GM2 – GM2AP;

sulfatides - (Sap-B)2 ) (and Michaelis complexes with their catabolic

hydrolases).SapA forms lipoprotein discs (2 SapA, 8-10 PL, Prive).

Inherited deficiencies of LLBPs (NPC-2, GM2AP, Sap A, B, C, D) cause fatal

diseases (prosaposin (-/-) : SL and membrane storage, defective skin barrier).

LLBPs (GM2AP, Saps A,B,C…) are regulated by lipids and

• transfer lipids from donor to acceptor vesicles,

• are fusogenic (GM2AP, Sap-D, Sap-C…..), and

• disintegrate BMP rich and cholesterol poor vesicles.

Lysosomal lipid binding proteins

(SAPs and NPC2)

IMs are adjusted for degradation, BMP is generated and

cholesterol leaves inner vesicles of late endosomes

1. Membrane lipids regulate cholesterol transfer by NPC-2 (BMP… , Cer , SM )

2. Digestion of SM(15%) by ASM enhances cholesterol transfer by NPC-2 (3fold)

3. ASM is a phospholipase C, cleaves PA, PG, PC, lyso-PC, SM and 17 other PLs

4. Anionic membrane lipids stimulate ASM: PA and PG 7-14fold; BMP 3fold

5. Diacylglycerol – a hydrolysis product of PLs by ASM- stimulates ASM activity

6. High cholesterol content inhibits PC, hydrolysis by ASM, but less SM cleavage

SM

Sphingosine

pH

Glycocalix

NPC-2

NPC-1

Ring Finger

Lateendosome

intraendosomalvesicle

ASM

?

?

sphingomyelin ceramide cholesterol

GlcCer

Ceramide

+ Fatty acid

5.5

pH 4.8

NTD

SM

(IM)

•Expansion of lysosomal compartment at the expense of cytosol and other

organelles

•Impaired digestion of macromolecules: Inhibition of catabolic enzymes and

proteins (SM inhibits NPC-2 and lipid sorting, cholesterol inhibits Sap-A, -B

etc., CADs inhibit catabolic steps and trigger proteolysis of ASM etc.)

•Starvation of neurons by impaired digestion and traffic jams in lysosomes

(cellular stomachs reduce their nutrient supply: Fe++, B12, FAs, AAs, CHO,

sphingoid bases, salvage pathways).

•Further mechanisms:

- Accumulation of toxic cationic lipids; galactosylsphingosine (GalSo)

(psychosine hypothesis, Krabbe), GlcSo, So, Sa.

-Release of cytokines,activation of microglia, influx of macrophages.

- CADs (Desipramine) impair lysosomal digestion, trigger proteolysis of

ASM and other catabolic hydrolases.

Pathologic mechanisms caused by lipid storage in late endosomes and lysosomes

Lysosomal lipids in LUVs stimulate the enzymatic GlcCer hydrolysis

in the presence and also in the absence of Sap-C.

+Sap-C

-Sap-C

A, assays were conducted with GlcCer as substrate in the absence (○) and presence of Sap-C (2.5 μm) (•), using LUVs with various proportions of synthetic BMP (0–40 mol %). B, assays

were carried out with varying concentrations of PI in LUVs, with (•) and without (○) the addition of 2.5 μm Sap-C, keeping the total lipid concentration in the assays constant.


rgl Sap-B (5 µM)

-2000

-1000

0

1000

2000

0 100 200 300 400

Time (s)

Resp

on

se U

nit

s (

RU

)

pH 4.2

pH 7.0

pH 5.5

Sap-B: variant forms

-2000

0

2000

4000

6000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

r Sap-B,

deglycosylated

r Sap-B, Asn215His

r Sap-B, Asn215Gln

rgl Sap-B


-5000

-3000

-1000

1000

3000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

0

40

20

Chol

(mol %)

Patient:

53825


-5000

-3000

-1000

1000

3000

0 100 200 300 400

Time (s)

Re

sp

on

se

Un

its

(R

U)

0

40

20

Chol

(mol %)

5

3825

BMP 14 mol%

gSap-B mobilizes lipids from BMP rich and

cholesterol poor membranes at acidic pH values

Plasmon resonance, Remmel, N. et al. (2006)

Lysosomal lipids in LUVs stimulate the enzymatic hydrolysis of ganglioside GM2 in the presence of GM2AP.

Werth N et al. J. Biol. Chem. 2001;276:12685-12690

All assays were conducted with

ganglioside GM2-carrying LUVs

as substrates in the absence (□)

and presence (■) of GM2AP (0.5

μm) using LUVs with various

proportions of synthetic BMP (0–

25 mol %) (A) or PI (0–30 mol %)

(B).

PA, sulfatides and

BMP plus Chol stimulate to a

similar extent.

BMP and PI stimulate the degradation of membrane-bound ceramide in the absence of SAPs

BMP


Acid ceramidase activity was measured in the presence of increasing concentrations of BMP (▪) and PI (●) in ceramide-bearing LUVs in the absence of SAPs. The data presented are the means of three determinations. All individual values were in the range of ±5 up to ±10% of the mean.

Rate increases with curvature of liposomes

Sap-D stimulates up to 3fold

PI

BASM

SM PC

Cer

Ch

ol

Sti

mu

lati

on

/ in

hib

itio

n b

y

DAG

Ce

rD

AG

FA

MA

G

0 10 20 30 40mol%

0 10 20 30 40mol%

Anionic lipids (20 mol%): PA, PG BMP

A

Choltransfer NPC2

SM

Cer DAG

ASM

PC

host lipid (PC)SM

Cer DAG

Cholesterol

anionic lipids

stimulation inhibition

Membrane lipids regulates ASM activity

and cholesterol transfer by NPC2


GM1 galactosidase-b-

Sialidase

Arylsulfatase A

b-

b-Hexosaminidase A

Hexosaminidase B


Sphingomyelinase



GM1 galactosidase

-b-

-b-

Ceramidase

(GM2-Gangliosidoses,AB, B, 0 Variant)

(Sialidosis)

a-Galacto-sidase A

(Fabry)

(Sandhoff)

(Fabry)

(Krabbe)


(Gaucher)

(Farber)

GM1

GM2

GM3

LacCer

GlcCer

Cer

Sphingosine

Sulfatide

DiGalCer


Globoside

GalCer

Glucosylceramidase

a- Galactosidase A

b-Hexosaminidase


GM1 galactosidase-b-GM1 galactosidase-b-

Sialidase

Arylsulfatase A

b-

b-Hexosaminidase A

Hexosaminidase B


Sphingomyelinase



GM1 galactosidase

-b-

-b-

Ceramidase

(GM2-Gangliosidoses,

(Sialidosis)

a-Galacto-sidase A

(Fabry)

(Sandhoff)

(Fabry)

(Krabbe)


(Gaucher)

(Farber)

GM1

GM2

GM3

LacCer

GlcCer

SphingomyelinCer

Sphingosine

Sulfatide

DiGalCer


Globoside

GalCer

Glucosylceramidase

a- Galactosidase A

b-Hexosaminidase

Sap-C, Sap-D

GM2AP, Sap-B

Sap-B

Sap-B, Sap-C

Sap-C,

Sap-B

Sap-B

Sap-B

Sap-C

GM2-AP

Lysosomal sphingolipid degradation

Sandhoff, K. and Kolter, T. (1995) Naturwissenschaften, 82, 403-413

Summary

NPC-2 is a cholesterol-binding and -transfer protein needed for secretion of

cholesterol from intraluminal vesicles (IMs) of late endosomes (SM inhibits,

PA, PG & BMP stimulate). NPC-2 deficiency causes NPC, ASM deficiency

NPA & NPB disease

LLBPs (GM2AP, saposins A, B, C, D) are needed for sphingolipid- and

membrane-degradation at intraluminal lysosomal membranes (lipid phase

problem). They bind lipids, transfer lipids, some fuse vesicles, and

disintegrate lipid vesicles at low pH.

rgSap-A and rgSap-B solubilize liposomal lipids at low pH, low cholesterol

and high BMP levels. Variant saposins of patients are inactive.

Blocks in SL-catabolism cause fatal neurodegenerative lipid storage

diseases. Prosaposin and ßGlcase(-/-):skin barier broken; Collodion babies;

O-acyl-VLC-GlcCers up.

Cationic lipids (GalSo in Krabbe, GlcSo in Gaucher, So&Sa)are cytotoxic.

Desipramine (CAD, a lipid !) interferes with lipid catabolism and triggers

proteolytic degradation of ASM and other hydrolases.

Gal- (1-4)-Glc-Cerb

GalCer- -galactosidaseb

Sap-B

Sandhoff

Ceramide

Acid ceramidaseSap-D

Farber

FabrySialidosis

Glucosylceramid- -glucosidasebSap-C

Sphingomyelinase

Fabry

Krabbe

Gaucher

Niemann-Pick A and B

Lactosylceramide

Gal- (1-1)-Cerb

Galactosylceramide

Gal- (1-3)-Gal-Cera

Digalactosylceramide

GM1- -galactosidasebSap-B and Sap-C

Sap-B

SialidaseSap-B

a-Galactosidase A

Gal- (1-4)-Gal-Glc-Cera


GalNAc- (1-3)-Gal-Gal-Glc-Cerb

Globoside

b-Hexos-aminidase A,B

Galactosylceramide- -galactosidasebSap-A

Tay-Sachs, SandhoffAB variant

GM1-Gangliosidosis

GalNAc- (1-4)-Gal-Glc-Cerb

GM2

NeuAc

GM3

b-Hexosaminidase AGM2-Activator

GM1- -galactosidasebGM2-Activator, Sap-B GM1-Gangliosidosis

GM1

-Hexosaminidase A, Bb

GM2-Activator

GM1- -galactosidaseb

Sandhoff

Glc- (1-1)-Cerb

Gal- (1-3)-GalNAc-Gal-Glc-Cerb

GA1


GA2

Glucosylceramide

Metachromaticleukodystrophy

SulfatideO S-3-Gal-Cer3

Sphingomyelin

Sphingosine

Arylsulfatase ASap-B

a-Galactosidase A

NeuAc


aNeuAc- (2-3)-Gal- (1-4)-Glc-Cerb


Lipid substrate (*GM2) :

Its turnover in patient`s cells correlates with:

- Patient`s celluar Hex A & GM2AP (GM2 cleaving)

activity and with the clinical course of the disease.

- But the clinical course hardly correlates with

patient`s enzyme activity on soluble,

artificial, synthetic substrates & the gene mutations.

The latter concepts ignore the influence of :

- (Patient`s) enzyme specificity against lipids,

- Activity and specificity of essential, promiscuous

and multifunctional SAPs,

- Extensive regulation of lipid turnover by membrane

lipids at luminal vesicular surfaces.

• NPC-2 transfer of cholesterol between vesicles:

- Is stimulated by BMP, PA, PG and inhibited by SM down to 10%.

- PG, PA and BMP stimulate ASM up to 14 fold and release the block by

SM.

• Results suggest a sequential pathway of lipid degradation at luminal IMs during

endocytosis:

- At late endosomes PM derived anionic PLs (PG, PA) stimulate ASM to

degrade SM, thereby releasing the block of cholesterol egress by NPC-2

inhibition. ASM also degrades PG, PA, and other PLs, triggering

loss of bilayer structure and barrier function of luminal membranes.

- Generation of BMP and reduction of cholesterol levels in IMs activates

SAPs (and hydrolases) needed for effective degradation GLS and

ceramides.

- Cationic lipids are toxic and inhibit catabolic steps (GalSo (Krabbe), GlcSo,

So, Sa). CADs trigger proteolysis of ASM & other hydrolases and induce a

phospholipidoses.

Perspectives:

Membrane lipids regulate activity of endolysosomal proteins

Human prosaposin

protein domain

precursor coding region

noncoding region n insertion of 0, 6, 9 bp of Exon 8, 8‘

glycosylation sites

cysteine residues

n

A B

ATG AAATAG

0 0,5 1,0 1,5 2,0 2,5 kb

prosaposin

deficiency

PS P S

P

S

phosphorylation of CHO

sulfatation of CHO

protein domain

precursor coding regionprecursor coding region

noncoding regionnoncoding regionnoncoding region n insertion of 0, 6, 9 bp of 8, 8‘n insertion of 0, 6, 9 bp of 8, 8‘

glycosylation sites

cysteine residues

n

A B

ATG AAATAG

0 0,5 1,0 1,5 2,0 2,5 kb

MLD Gaucher

PPSS PP SS

PP

Krabbe

disease causing mutations

Sandhoff et al (2001) in: The Metabolic

and Molecular Bases of Inherited Disease

Lipid Storage and Threshold Theory

Patient

(Infantile)

Residual catabolic activity

(juvenile)

]1max

[

1][

-

Vi

VKm

S eq

Normal

Lysosome

Vi

[S]eq

Conzelmann and Sandhoff (1983/84), Dev. Neurosci., 6, 58-71

Wilkening, et al. (1998)

1. Induction of lipidoses in rats Lüllmann et al. (1978)

2. Detachment of acid sphingomyelinase from anionic

liposomes Kölzer et al. (2004)

3. Proteolytic degradation of acid sphingomyelinase and

other lysosomal enzymes by desipramine-treated

cultured fibroblasts. Hurwitz et al. (1994)

Cytoplasmic Inclusion body; x 78400

Chromaffin cell of a rat treated with

1-chloro-amitriptyline (120 mg/kg 10 wk)

N

NH

CH3

N

CH3

CH3

Cl

Chloroquine(Antimalaria)

N

NCH3

H

Desipramine(Antidepressant)

Propranolol(b-Adrenoreceptor-antagonist)

Cationic Amphiphilic Drugs (CADs):

• Many drugs are CADs

• CADs are neutral at pH 7 and penetrate membranes

• They are protonated and trapped in lysosomes

Lysosome

-

-

-

-

-

-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP




activator protein

lysosomal enzyme

-

++

+

+++

++

+

+

+

+

+

+

-

-

-

-

+

LysosomeLysosome

-

-

-

-

-

-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP



-

-

-

-

-

-

--

HO

SAP-CSAP-D

acid

Ceramidase

Gluco-

cerebrosidase


BMPBMP




activator protein

lysosomal enzyme

--

++++

++

++++++

++++

++

++

++

++

++

++

--

--

--

--

++

O N CH3

CH3

OH H

CADs: Cationic amphiphilic drugs(lipids!)

induce a phospholipidosis: the molecular view

Michaelis Menten

Complex

A

Intraendolysosomal Membrane

Mechanism of GM2AP-liftase

Wright et al. (2003), J. Mol. Biol. 331, 951-64

Wendeler et al. (2004),Eur. J.Biochem. 271, 614-27 BWerth et al. (2001) J. Biol. Chem. 276, 12685

BMP (mol %)

5

10

20

25

PA,PI,DP,Sulf

(Chol 35 inhibts)

C(n=5,1)-TPD-GM2

(CH2)nO F3C

NNO

OH

HNHO

HOHO

O

O OH

O OH

O

OHHOO

OH

O

HN

OH

HOOC

O

OH

HONH

O

OH

O

-8000

-4000

0

4000

8000

0 90 180 270 360

Time (s)

Resp

on

se U

nit

s (

RU

)

(R

U)

2.5µM Cyt.-c

50mM NaCitrate

2.5µM gSap-A

20mM Chaps

Plasmon resonance studies: Liposomes were reversibly bound to the hydrophobic surface of the

sensor chip (dextran matrix derivatized with alkyl chains) and can be totally removed by detergent

(Chaps). Proteins that are not membrane active (cytochrome-C) bind to liposomes. Their curves

reach a plateau value and do not fall below the base line.

20 mM Chaps

2.5 µM gSap-A

50 mM NaCitrate

2.5 µM Cyt-C

Locatelli Hoops, S. et al. JBC (2006)

Lipid solubilization: Sap-A releases lipids from

liposomes bound to a sensor chip

Start--

MAG -

ASM

lyso-PC

lyso-PE

lyso-PA

lyso-PG

lyso-PI

lyso-PC-Plasm

NBD-PE

PC-Plasm

Biotin-PE

Palm-PE

lyso-PE-Plasm

DHP

+ _ _ _ _ _

+ + + +

lysoglycerophospholipids

- MAG

- DAG

SMlyso-SM

lyso-CPE

CPE

ASM

- Cer

- So

+ _ _ _ _

+ + +

sphingophospholipids

PC PA PG PI PS CLBMP(R/R)

BMP(S/S)

BMP(R/S)

PE

+ _ _ _ _ _ _ _ _ _ _

+ + + + + + + + +

glycerophospholipids

- 1-alkenylglycerol- DAG

- 1-alkenyl-2-acylglycerol

+ + + _ ___ __ _

+ + + +

plasmalogenSynthetic

phospholipids

A

C D E

B

Breiden, Oninla, Sandhoff, 2012

Micellar assay: 15 µg lipid/10 µg ASM/ 24 h at 37°C pH 4.5

ASM: recombinat HUMAN ASM expressed in insect Sf21 cells

(Lansmann et al., 2000)

ASM is a nonspecific phosoholipase C

BMP and GM2AP stimulate the hydrolysis of LUV-bound ganglioside GM2.

Werth N et al. J. Biol. Chem. 2001;276:12685-12690

BMP and GM2AP stimulate the hydrolysis of LUV-bound ganglioside GM2. The degradation of ganglioside GM2 inserted into LUVs doped with 0 mol % BMP (○), 5 mol % BMP (■), 10 mol % BMP (●), 20 mol % BMP (▴), or 25 mol % BMP (▪) was measured in the presence of increasing concentrations of GM2AP (0–2.2 μm).

The degradation was measured with LUVs doped with 0 mol % PA (×), 5 mol % PA (•), 10 mol % PA (▴), or 20 mol % PA (▪) and increasing concentrations of SAP-C. All assay mixtures were prepared as described under “Experimental Procedures” and contained increasing proportions of PA in LUVs.

Wilkening et al, 2000, JBC 273, 30271-8

PA and SAP-C stimulate hydrolysis of LUV-bound glucosylceramide.

Anionic lipids in LUVs stimulate the enzymatic GlcCer hydrolysis in the presence and absence of SAP-C.


A, assays were conducted with GlcCer as substrate in the absence (○) and presence of SAP-C (2.5 μm) (•) using LUVs with various proportions of synthetic BMP (0–40 mol %). B, assays were carried out with varying concentrations of PI in LUVs, with (•) and without (○) the addition of 2.5 μm SAP-C, keeping the total lipid concentration in the assays constant. C, GlcCer carrying LUVs with or without PA were doped with increasing proportions of dolichol (0–10 mol %) and assayed for enzymatic GlcCer hydrolysis as follows: without SAP-C (○), with 2.5 μm SAP-C (•), with 10 mol % PA (▵), and with 10 mol % PA and 2.5 μm SAP-C (▴).D, assays were performed with varying concentrations of dolichol phosphate (DP) (0–10 mol %) with 2.5 μm SAP-C (•) or no SAP-C (○).

+ Sap-C

- Sap-C

- Sap-C

+ Sap-C

Gal- (1-4)-Glc-Cerb

GalCer- -galactosidaseb

Sap-B

Sandhoff

Ceramide

Acid ceramidaseSap-D

Farber

FabrySialidosis

Glucosylceramid- -glucosidasebSap-C

Sphingomyelinase

Fabry

Krabbe

Gaucher

Niemann-Pick A and B

Lactosylceramide

Gal- (1-1)-Cerb

Galactosylceramide

Gal- (1-3)-Gal-Cera

Digalactosylceramide

GM1- -galactosidasebSap-B and Sap-C

Sap-B

SialidaseSap-B

a-Galactosidase A

Gal- (1-4)-Gal-Glc-Cera


GalNAc- (1-3)-Gal-Gal-Glc-Cerb

Globoside

b-Hexos-aminidase A,B

Galactosylceramide- -galactosidasebSap-A

Tay-Sachs, SandhoffAB variant

GM1-Gangliosidosis


GM2

NeuAc

GM3

b-Hexosaminidase AGM2-Activator

GM1- -galactosidasebGM2-Activator, Sap-B GM1-Gangliosidosis

GM1

-Hexosaminidase A, Bb

GM2-Activator

GM1- -galactosidaseb

Sandhoff

Glc- (1-1)-Cerb


GA1


GA2

Glucosylceramide

Metachromaticleukodystrophy

SulfatideO S-3-Gal-Cer3

Sphingomyelin

Sphingosine

Arylsulfatase ASap-B

a-Galactosidase A

NeuAc


aNeuAc- (2-3)-Gal- (1-4)-Glc-Cerb


Documents

Membrane lipids regulate glycosphingolipid catabolism, its ... · LIMES, Membrane Biology and Lipid Biochemistry Unit Kekulé-Institut Gerhard-Domagk-Str. 1, 53121, Bonn Universität